Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04798664 · ClinicalTrials.gov registry record · NA
Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 3,228
- Enrollment target
NCT04798664: Completed NA study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT04798664 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 3,228 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (130% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04798664, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,228 participants
- Enrollment target
Study Summary
To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.
Primary Outcome
The primary outcome measure is sustained abstinence for 6 months, and will require self-report of smoking cessation followed by biochemical confirmation at 2 weeks, 3, and 6 months.
Interventions
- BEHAVIORAL Financial Incentives
- BEHAVIORAL Mobile Health Application
- BEHAVIORAL Removal of Financial Barriers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,228 participants |
| Start Date | 2021-05-17 |
| Est. Completion | 2025-04-29 |
| Phase | NA |
What the finished NCT04798664 record still lists
NCT04798664 is an interventional study that assigns participants to a tested intervention. Its 3,228 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (130% higher).
The record links to 0 conditions, and to 3 interventions - of which Financial Incentives is the first listed.
NCT04798664 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04798664 about?
NCT04798664 is a clinical study titled "Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening". To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.
What is the current status of trial NCT04798664?
This trial is currently completed. It is a NA study. The enrollment target is 3,228 participants. The study started on 2021-05-17. Estimated completion is 2025-04-29.
What interventions are being tested in trial NCT04798664?
The interventions under investigation include: Financial Incentives (BEHAVIORAL), Mobile Health Application (BEHAVIORAL), Removal of Financial Barriers (BEHAVIORAL).
Who is sponsoring clinical trial NCT04798664?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04798664's enrollment target sits among peer trials
3,228 37th of 2000 higher than 1,964 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06587529 · 3,218 participants · NA
Rigorous Evaluation of the READY to Stand Curriculum to Prevent the Commercial Sexual Exploitation of Children
- NCT06760507 · 3,209 participants · NA
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
- NCT06953375 · 3,250 participants · NA
Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty
- NCT02043457 · 3,200 participants
Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI